Literature DB >> 15064015

Computed tomography (CT) evaluation of breast cancer patients with osteolytic bone metastases undergoing palliative radiotherapy--a feasibility study.

Edward Chow1, Lori Holden, Joel Rubenstein, Monique Christakis, Katharina Sixel, Marjan Vidmar, Joel Finkelstein, Charles Hayter, Andrew Loblaw, Rebecca Wong, Ewa Szumacher, Cyril Danjoux.   

Abstract

Twenty-five patients with osteolytic metastases had computed tomography (CT) scans before and 3 months after palliative radiotherapy. The median % density change following single 8Gy, 20Gy/5#, 30Gy/10# were: 128 (range 98-255), 141 (79-342), and 145 (65-235), respectively. It is feasible to evaluate remineralization of osteolytic lesions with palliative radiotherapy.

Entities:  

Mesh：

Year:  2004        PMID： 15064015     DOI： 10.1016/j.radonc.2004.01.009

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  11 in total

1.  Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria.

Authors:  V Vassiliou; D Andreopoulos
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

2.  Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastases.

Authors:  E Amir; C Whyne; O C Freedman; M Fralick; R Kumar; M Hardisty; M Clemons
Journal:  Clin Exp Metastasis       Date:  2009-03-06       Impact factor: 5.150

3.  A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid.

Authors:  Carlo C Quattrocchi; Daniele Santini; Paola Dell'aia; Sara Piciucchi; Emanuele Leoncini; Bruno Vincenzi; Rosario Francesco Grasso; Giuseppe Tonini; Bruno Beomonte Zobel
Journal:  Skeletal Radiol       Date:  2007-10-03       Impact factor: 2.199

4.  Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: is there a correlation between clinical status of patients and type of bone metastases?

Authors:  Vassilios Vassiliou; Christine Kalogeropoulou; Theodoros Petsas; Michael Leotsinidis; Dimitrios Kardamakis
Journal:  Clin Exp Metastasis       Date:  2007-02-13       Impact factor: 4.510

5.  Bone density as a marker for local response to radiotherapy of spinal bone metastases in women with breast cancer: a retrospective analysis.

Authors:  Robert Foerster; Christian Eisele; Thomas Bruckner; Tilman Bostel; Ingmar Schlampp; Robert Wolf; Juergen Debus; Harald Rief
Journal:  Radiat Oncol       Date:  2015-03-07       Impact factor: 3.481

6.  Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases.

Authors:  Carlo C Quattrocchi; Paola Dell'Aia; Yuri Errante; Filomena Occhicone; Daniela Longo; Vladimir Virzì; Giuseppe Tonini; Nicola Napoli; Daniele Santini; Bruno Beomonte Zobel
Journal:  J Bone Oncol       Date:  2012-03-23       Impact factor: 4.072

7.  Limited short-term effect of palliative radiation therapy on quantitative computed tomography-derived bone mineral density in femora with metastases.

Authors:  Florieke Eggermont; Loes C Derikx; Nico Verdonschot; Gerjon Hannink; Robert S J P Kaatee; Esther Tanck; Yvette M van der Linden
Journal:  Adv Radiat Oncol       Date:  2016-11-10

8.  Bone Density Changes Following Radiotherapy to Vertebral Metastases.

Authors:  Garrett L Jensen; Ravi Gaddipati; Kendall P Hammonds; Andrew Morrow; Gregory P Swanson
Journal:  Cureus       Date:  2021-06-03

9.  A novel study investigating the therapeutic outcome of patients with lytic, mixed and sclerotic bone metastases treated with combined radiotherapy and ibandronate.

Authors:  Vassilios Vassiliou; Christine Kalogeropoulou; Efstathia Giannopoulou; Michael Leotsinidis; Irine Tsota; Dimitrios Kardamakis
Journal:  Clin Exp Metastasis       Date:  2007-04-18       Impact factor: 4.510

10.  The influence of fractionated radiotherapy on the stability of spinal bone metastases: a retrospective analysis from 1047 cases.

Authors:  Tanja Sprave; Katharina Hees; Thomas Bruckner; Robert Foerster; Tilman Bostel; Ingmar Schlampp; Rami El Shafie; Nils Henrik Nicolay; Juergen Debus; Harald Rief
Journal:  Radiat Oncol       Date:  2018-07-24       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.